LINC00632 and breast cancer: As shown in Figure 1A, the expression level of CDR1as was relatively higher in glioblastoma multiforme (GBM), neuroblastoma (NRBL), sarcoma (SARC), secretory cancer (SECR), breast cancer (BRCA), and melanoma (SKCM).